当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析 - 资产负债表

易明医药

(002826)

  

流通市值:26.92亿  总市值:27.88亿
流通股本:1.84亿   总股本:1.91亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金423,877,562.54499,337,390.47433,557,153.78537,664,815.13
  交易性金融资产300,000,000200,000,000200,000,000-
  应收票据及应收账款32,201,351.3223,034,712.5325,771,388.3629,534,633.32
  其中:应收票据2,585,0692,833,5583,744,34016,790,433.34
        应收账款29,616,282.3220,201,154.5322,027,048.3612,744,199.98
  预付款项17,045,127.849,017,074.841,762,232.531,090,324.9
  其他应收款合计2,803,825.32,447,826.912,292,107.112,618,801.29
  存货50,884,872.9854,016,658.557,431,057.3659,782,766.19
  一年内到期的非流动资产2,989,346.662,794,387.972,386,824.892,424,562.07
  其他流动资产81,956.1722,058.4373,528.76566,359.06
  流动资产合计829,884,042.81790,670,109.65723,274,292.79633,682,261.96
非流动资产:
  长期应收款8,953,611.79,054,379.889,422,615.289,344,055.16
  其他非流动金融资产33,387,288.3633,425,410.53,479,978.483,534,999.09
  固定资产320,680,689.01324,171,038.14327,509,990.04331,295,695.64
  无形资产19,996,590.6618,828,173.1819,005,187.2119,202,577.32
  商誉16,668,928.8916,668,928.8916,668,928.8916,668,928.89
  递延所得税资产3,696,584.83,706,677.843,865,859.313,839,106.67
  其他非流动资产--64,000106,750
  非流动资产合计403,383,693.42405,854,608.43380,016,559.21383,992,112.77
  资产总计1,233,267,736.231,196,524,718.081,103,290,8521,017,674,374.73
流动负债:
  短期借款55,390,00028,800,000-11,259,529.05
  应付票据及应付账款210,166,356.58194,343,413.16145,225,202.24105,834,727.82
        应付账款210,166,356.58194,343,413.16145,225,202.24105,834,727.82
  合同负债515,163.414,773,559.945,415,643.011,950,059.15
  应付职工薪酬30,126,863.2813,711,972.5826,417,220.7325,660,495.33
  应交税费22,746,019.4715,649,779.5911,880,786.039,316,643.82
  其他应付款合计64,567,924.770,327,911.8670,816,562.2842,405,830.75
  其他流动负债66,971.24620,562.81704,033.59253,507.69
  流动负债合计383,579,298.68328,227,199.94260,459,447.88196,680,793.61
非流动负债:
  递延收益4,493,444.584,652,310.034,811,175.484,970,040.93
  非流动负债合计4,493,444.584,652,310.034,811,175.484,970,040.93
  负债合计388,072,743.26332,879,509.97265,270,623.36201,650,834.54
所有者权益(或股东权益):
  实收资本(或股本)190,677,750190,677,750190,677,750190,677,750
  资本公积260,062,376.16251,014,006.5244,083,206.49232,644,488.45
  减:库存股117,074,449.5657,346,995.3557,346,995.3548,147,160.64
  其他综合收益-1,223,774.48-1,041,388.67-756,108.55-102,466.31
  专项储备9,441,895.069,709,913.719,250,685.788,487,608.83
  盈余公积27,780,80927,780,80927,780,80927,780,809
  未分配利润475,530,386.79442,851,112.92424,330,881.27404,682,510.86
  归属于母公司股东权益合计845,194,992.97863,645,208.11838,020,228.64816,023,540.19
  股东权益合计845,194,992.97863,645,208.11838,020,228.64816,023,540.19
  负债和股东权益合计1,233,267,736.231,196,524,718.081,103,290,8521,017,674,374.73
公告日期2026-10-282026-08-272026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑